English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Poster Presentations - PO1M Pathogenesis: PO1.M.4OBJECTIVES: Renal inflammation is a hallmark of lupus nephritis. Hyaluronan (HA) is a non-sulfated glycosaminoglycan ubiquitous in the extracellular environment of all cells. Tissue inflammation and fibrosis are associated with increased HA levels. Increased glomerular and tubular-interstitial HA expression has been shown in lupus nephritis, but its role in pathogenesis remains to be defined. Using 4-methylumbelliferone (MU), a specific inhibitor of HA synthesis, we examined the role of HA on renal histopathology and clinical manifestations in NZB/W mice with lupus nephritis. METHODS: Twenty-four female NZB/W mice with active nephritis denoted by persistent proteinuria >300mg/dl were divided into 4 groups and administered saline or MU (0.5, 1.0 or 5.0 mg/kg/day) by oral gavage for 12 weeks. They were then sacrificed and the urine, blood and kidneys analysed. RESULTS: MU significantly reduced serum HA levels in a dose-dependent manner compared to controls (p<0.05). This was associated with reductions in anti-dsDNA antibody titre (1316±718ng/ml vs 807±381ng/ml, control vs 5mg/kg/day MU, p<0.05), urine protein-to-creatinine ratio (23 vs 13 mg/mg creatinine for corresponding groups, p<0.05), and splenomegaly (0.16g vs 0.12 g for corresponding groups, p<0.05). Mice with active nephritis showed glomerular hypertrophy and increased intra-renal expression of CD4, CD8, CD19, CD23, CD45 and Mac-1. The intra-glomerular expression of HA and its receptor CD44, as well as that of IL-6 and MCP-1, was also increased. These changes were abrogated in mice treated with MU at 1 and 5 mg/kg/day. CONCLUSIONS: Our data suggest that HA participates in the pathogenesis of inflammation and histopathologic manifestations of renal injury in lupus nephritis, and thus may be a potential target for therapy.link_to_OA_fulltextThe 9th International Congress on Systemic Lupus Erythematosus (SLE), Vancouver, Canada, 24-27 June 2010. In Lupus, 2010, v. 19 n. 1, suppl., p. 115-116, abstract no. PO1.M.

The 9th International Congress on SLE June 24 – 27 2010, Vancouver, Canada